Chemed Corp (CHE)
Working capital turnover
| Mar 31, 2025 | Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 | Dec 31, 2020 | Sep 30, 2020 | Jun 30, 2020 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue (ttm) | US$ in thousands | 2,482,047 | 2,431,287 | 2,377,206 | 2,335,557 | 2,293,493 | 2,264,417 | 2,225,159 | 2,187,099 | 2,164,571 | 2,134,963 | 2,129,287 | 2,141,482 | 2,142,450 | 2,139,261 | 2,131,572 | 2,121,202 | 2,091,145 | 2,079,583 | 2,068,618 | 2,020,934 |
| Total current assets | US$ in thousands | 394,748 | 394,748 | 490,437 | 464,612 | 539,617 | 500,843 | 394,539 | 337,160 | 262,221 | 272,612 | 198,869 | 203,146 | 184,751 | 230,286 | 200,564 | 269,086 | 346,974 | 329,403 | 270,596 | 189,307 |
| Total current liabilities | US$ in thousands | 285,695 | 285,695 | 264,779 | 261,753 | 281,974 | 312,050 | 297,219 | 302,487 | 283,460 | 297,205 | 298,150 | 285,068 | 279,651 | 302,399 | 286,086 | 267,402 | 290,215 | 299,108 | 329,163 | 318,516 |
| Working capital turnover | 22.76 | 22.29 | 10.53 | 11.51 | 8.90 | 11.99 | 22.86 | 63.08 | — | — | — | — | — | — | — | 1,259.62 | 36.84 | 68.64 | — | — |
March 31, 2025 calculation
Working capital turnover = Revenue (ttm) ÷ (Total current assets – Total current liabilities)
= $2,482,047K ÷ ($394,748K – $285,695K)
= 22.76
Chemed Corp's working capital turnover has fluctuated over the periods mentioned in the data.
The working capital turnover was not available for June 30 and September 30, 2020, and September 30, 2021. The turnover ratio was notably high at 1,259.62 for June 30, 2021, indicating a very efficient use of working capital to generate sales during that period.
Subsequently, the turnover ratio decreased to 63.08 for June 30, 2023, showing a significant decline in efficiency in using working capital to generate revenue. However, it slightly improved to 22.29 for December 31, 2024, and remained relatively stable around that level for the subsequent periods up to March 31, 2025.
It is important for Chemed Corp to consistently monitor and manage its working capital turnover to ensure optimal utilization of its resources and maximize operational efficiency.
Peer comparison
Mar 31, 2025